VolitionRX Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About VolitionRX Ltd
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
/ 
Frequently asked questions
To buy VolitionRX Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for VolitionRX Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for VolitionRX Ltd is VNRX:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
VolitionRX Ltd has its primary listing on NYSE American. You can trade VolitionRX Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, VolitionRX Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include VolitionRX Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like VolitionRX Ltd.